MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer

Y R Park1,2, S L Kim1,2, M R Lee2,3

  • 1Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Republic of Korea.

Abstract

Insights

MicroRNA-30a (miR-30a) is downregulated in colorectal cancer (CRC), inhibiting metastasis by targeting TM4SF1. Restoring miR-30a may offer a new therapeutic strategy for CRC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Colorectal cancer (CRC) is a major global health concern.
  • MicroRNAs (miRNAs) are key regulators of gene expression in cancer development.
  • The specific role of microRNA-30a-5p (miR-30a) in CRC remains largely unelucidated.

Purpose of the Study:

  • To investigate the function of miR-30a in colorectal cancer.
  • To identify the molecular mechanisms underlying miR-30a's role in CRC progression.
  • To explore miR-30a as a potential therapeutic target for CRC.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to assess miR-30a and TM4SF1 expression.
  • Cell migration and invasion assays (wound healing, trans-well) to evaluate CRC cell behavior.
  • Luciferase reporter assays and bioinformatics to validate TM4SF1 as a miR-30a target.
  • Western blotting and immunohistochemistry to analyze EMT regulators (E-cadherin, VEGF).

Main Results:

  • miR-30a was significantly downregulated in CRC tissues and cell lines, inversely correlated with advanced stage and lymph node metastasis.
  • Overexpression of miR-30a suppressed CRC cell migration and invasion.
  • miR-30a directly targeted and downregulated TM4SF1 expression.
  • miR-30a modulated the expression of EMT markers, decreasing VEGF and increasing E-cadherin.

Conclusions:

  • miR-30a acts as a tumor suppressor in CRC by inhibiting cell migration and invasion.
  • miR-30a regulates key metastatic factors including TM4SF1, VEGF, and E-cadherin.
  • miR-30a represents a promising therapeutic target for mitigating colorectal cancer lymph node metastasis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Microtubules in Cell Motility01:24

Microtubules in Cell Motility

Microtubules are thick hollow cylindrical proteins that help form the cytoskeleton. Microtubules have varied roles in the cell. These filaments help form cellular appendages like cilia and flagella, which are responsible for locomotion. The cilia arise from basal bodies, separated from the main body by a membrane-like structure forming the transition zone. This zone is the gate for the entry of lipids and proteins, creating a unique composition of lipids and proteins in the ciliary membrane and...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K